MIG-7 controls COX-2/PGE2-mediated lung cancer metastasis (Q34311532)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

1 August 2017

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

MIG-7 controls COX-2/PGE2-mediated lung cancer metastasis (English)

1 reference

1 August 2017

1 reference

1 reference

Ming-Yi Ho

1 reference

1 August 2017

Shu-Mei Liang

series ordinal

1 reference

1 August 2017

Shao-Wen Hung

series ordinal

1 reference

1 August 2017

Chi-Ming Liang

series ordinal

1 reference

1 August 2017

language of work or name

English

0 references

publication date

13 November 2012

1 reference

1 August 2017

1 reference

1 August 2017

1 reference

1 August 2017

1 reference

1 August 2017

page(s)

439-449

1 reference

The role of glycogen synthase kinase 3 beta in the transformation of epidermal cells

1 August 2017

cites work

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/citations/10.1158/0008-5472.CAN-06-4665

Vioxx withdrawal alarms cancer prevention researchers

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-12-2220

Membrane-type matrix metalloproteinase-1 (MT1-MMP) is a processing enzyme for human laminin gamma 2 chain.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-12-2220

Lung cancer and cyclooxygenase-2

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-12-2220

Prostaglandin E2 Stimulates the beta-catenin/T cell factor-dependent transcription in colon cancer

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-12-2220

Risk of cardiovascular events associated with selective COX-2 inhibitors

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-12-2220

Activation of β-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem cell-like characters

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-12-2220

Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-12-2220

IL-27 directly restrains lung tumorigenicity by suppressing cyclooxygenase-2-mediated activities

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-12-2220

Raf activation by Ras and promotion of cellular metastasis require phosphorylation of prohibitin in the raft domain of the plasma membrane.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-12-2220

Cyclooxygenase as a target in lung cancer

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-12-2220

Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-12-2220

Recombinant viral protein promotes apoptosis and suppresses invasion of ovarian adenocarcinoma cells by targeting α5β1 integrin to down-regulate Akt and MMP-2

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-12-2220

Regulation of phosphorylation of Thr-308 of Akt, cell proliferation, and survival by the B55alpha regulatory subunit targeting of the protein phosphatase 2A holoenzyme to Akt.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-12-2220

New molecularly targeted therapies for lung cancer

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-12-2220

Allosteric AKT inhibitors as a targeted cancer therapy

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-12-2220

Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-12-2220

Structure, regulation and function of PKB/AKT--a major therapeutic target

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-12-2220

Recombinant VP1, an Akt inhibitor, suppresses progression of hepatocellular carcinoma by inducing apoptosis and modulation of CCL2 production

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-12-2220

PI3K/Akt signalling pathway and cancer.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-12-2220

Complex networks orchestrate epithelial-mesenchymal transitions

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-12-2220

Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-12-2220

Mediators of PGE2 synthesis and signalling downstream of COX-2 represent potential targets for the prevention/treatment of colorectal cancer

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-12-2220

The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-12-2220

The aurora kinase A regulates GSK-3beta in gastric cancer cells

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-12-2220

Overexpression of carcinoma and embryonic cytotrophoblast cell-specific Mig-7 induces invasion and vessel-like structure formation

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-12-2220

Connecting COX-2 and Wnt in cancer

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-12-2220

Selection of Invasive and Metastatic Subpopulations from a Human Lung Adenocarcinoma Cell Line

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-12-2220

Adverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events: meta-analysis of randomized trials

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-12-2220

Multiple pathways regulated by the tumor suppressor PP2A in transformation

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-12-2220

HGF and ligation of alphavbeta5 integrin induce a novel, cancer cell-specific gene expression required for cell scattering

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-12-2220

Eicosanoids and cancer

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-12-2220

Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells

2 references

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-12-2220

9 February 2024

https://opencitations.net/index/api/v1/citations/10.1002/JCP.20560

Targeting migration inducting gene-7 inhibits carcinoma cell invasion, early primary tumor growth, and stimulates monocyte oncolytic activity

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-12-2220

Prostaglandin E2 increases growth and motility of colorectal carcinoma cells

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-12-2220

Identifiers

DOI

10.1158/0008-5472.CAN-12-2220

1 reference

1 August 2017

1 reference